Jazz closes $1.25B exchangeable notes offering; repurchases $225M shares

Jazz Pharmaceuticals plc

Completed $1.25B 1.875% exchangeable senior notes due 2032, including full $150M greenshoe exercise.
Net proceeds estimated at ~$1,226.4M; intended for general corporate purposes.
Initial exchange rate 2.8150 shares per $1,000 principal; exchange price ~$355.24 (42.5% premium).
Concurrently repurchased ~$225M of ordinary shares at $249.29 via private transactions.
Notes mature Sept 15, 2032; fully and unconditionally guaranteed by Jazz on senior unsecured basis.

item 1.01 item 2.03 item 3.02 item 8.01 item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.